Growth Metrics

Ocugen (OCGN) Current Deferred Revenue: 2014-2018

Historic Current Deferred Revenue for Ocugen (OCGN) over the last 4 years, with Dec 2018 value amounting to $238,000.

  • Ocugen's Current Deferred Revenue rose 114.41% to $238,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $238,000, marking a year-over-year increase of 114.41%. This contributed to the annual value of $238,000 for FY2018, which is 114.41% up from last year.
  • Latest data reveals that Ocugen reported Current Deferred Revenue of $238,000 as of Q4 2018, which was down 95.24% from $5.0 million recorded in Q3 2018.
  • In the past 5 years, Ocugen's Current Deferred Revenue ranged from a high of $7.5 million in Q2 2018 and a low of $111,000 during Q4 2017.
  • For the 3-year period, Ocugen's Current Deferred Revenue averaged around $1.6 million, with its median value being $248,500 (2017).
  • In the last 5 years, Ocugen's Current Deferred Revenue tumbled by 75.10% in 2016 and then spiked by 2,795.75% in 2018.
  • Quarterly analysis of 5 years shows Ocugen's Current Deferred Revenue stood at $219,000 in 2014, then skyrocketed by 85.84% to $407,000 in 2015, then remained steady at $407,000 in 2016, then slumped by 72.73% to $111,000 in 2017, then spiked by 114.41% to $238,000 in 2018.
  • Its Current Deferred Revenue was $238,000 in Q4 2018, compared to $5.0 million in Q3 2018 and $7.5 million in Q2 2018.